Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS

Yazhong Tao1,2,3, Xin Zhang1,2,3, Robert Zivadinov1,2,3, Michael G. Dwyer1,2,3, Cheryl Kennedy1,2,3, Niels Bergsland1,2,3, Deepa P. Ramasamy1,2,3, Jacqueline Durfee1,2,3, David Hojnacki1,2,3, Brooke Hayward1,2,3, Fernando Dangond1,2,3, Bianca Weinstock‐Guttman1,2,3, Silva Markovic‐Plese1,2,3
1EMD Serono, Inc. (B.H., F.D.), Rockland, MA.
2From the Departments of Neurology (Y.T., X.Z., S.M.-P.) and Microbiology and Immunology (S.M.-P.), University of North Carolina at Chapel Hill
3From the Departments of Neurology (Y.T., X.Z., S.M.-P.) and Microbiology and Immunology (S.M.-P.), University of North Carolina at Chapel Hill; Buffalo Neuroimaging Analysis Center (R.Z., M.G.D., C.K., N.B., D.R., J.D.), Department of Neurology (R.Z., M.G.D., C.K., N.B., D.R., D.H., J.D., B.W.-G.), State University of New York at Buffalo; and EMD Serono, Inc. (B.H., F.D.), Rockland, MA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1146/annurev.immunol.23.021704.115707

10.4049/jimmunol.0802226

10.1007/s10875-008-9251-y

Eyerich S, Eyerich K, Pennino D, et al.. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009;119:3573–3585.

10.1038/ni.1770

10.1038/ni1488

10.1038/ni1496

10.1038/nature07021

10.1038/nm1585

10.1084/jem.194.5.669

10.4049/jimmunol.1200887

10.2353/ajpath.2008.070690

10.1016/S0022-510X(00)00331-2

10.1016/j.jns.2009.03.016

10.1111/j.1552-6569.2007.00198.x

10.1358/mf.2009.31.1.1346612

10.1371/journal.pone.0091098

10.1002/ana.22366

10.4049/jimmunol.180.10.6988

10.4049/jimmunol.1301926

10.1016/j.neuroimage.2011.07.045

10.4049/jimmunol.1302580

10.4049/jimmunol.0803227

10.1038/ni.1767

Ma HL, Liang S, Li J, et al.. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008;118:597–607.

10.1002/art.24220

10.1111/j.0105-2896.2005.00293.x

10.1016/j.jneuroim.2013.04.021

10.1189/jlb.5A0813-463RR

10.1002/ana.21652

10.1016/j.bbi.2011.03.007

10.1172/JCI33342

10.1016/j.immuni.2008.03.011

10.1002/ana.22136

10.1034/j.1600-0404.2002.1o199.x

10.1212/WNL.58.7.1077